Adare Pharma Solutions is a global technology-driven contract development and manufacturing organisation (CDMO) providing end-to-end integrated services, from product development through commercial manufacturing and packaging, with small molecule expertise focusing on oral dosage forms for the pharmaceutical industry.
Adare’s specialised technology platforms provide taste masking, customised release, multiparticulate systems, and patient-centric dosing solutions. With a proven history in drug delivery, Adare’s facilities in the U.S. and Europe have developed and manufactured more than 65 products sold by customers worldwide.
SERVICES & CAPABILITIES
Adare Pharma Solutions provides comprehensive CDMO services, from the earliest stages of development to commercial manufacturing and packaging for both new and existing products, with expertise in complex formulations and patient-centric technologies.
TECHNOLOGIES
Adare’s industry-leading experts possess unparalleled experience in the development of unique dosage forms that provide taste masking, customised release, and patient-centric solutions. Our technology platforms overcome complex formulation challenges to improve the lives of all patients, with expertise in paediatric, geriatric, and dysphagic requirements.
FACILITIES
Adare operates facilities in the U.S. and Europe, staffed by over 750 employees. With a global manufacturing network, Adare offers integrated global and regional supply chains from state-of-the-art facilities in the U.S. and Europe. We deliver development-scale through commercial-scale production, with a continuum of highly specialised manufacturing services and capabilities to meet any customer’s oral solid dose needs.
- Technology Platform
• Solutions to overcome formulation challenges
• Taste masking
• Customised drug release
• Solubility enhancement
• ODTs and novel dosage forms
• Easily swallowed dosage forms for patients with difficulty swallowing
• Optimise efficacy, safety, and dosing frequency
• Increase therapeutic performance and patient acceptability
• Maximise dosing accuracy, flexibility, convenience
- Development
• Preformulation
• Formulation development of:
- Solid dose tablets
- Capsules
• Paediatric formulation
• Product design
• Formulation optimisation
• 3D screen printing capabilities
• Sourcing of APIs & excipients
• Analytical method development & validation
• Prototype development
• Small-scale non-GMP & GMP development capabilities
- Manufacturing
• Clinical & commercial manufacturing
• Global network of facilities
• Integrated regional supply chains
• Seamless scale-up & tech transfer
• Tableting & capsule filling
• Minitabs™
• Granulation and mixing
• Fluid bed processing
• Pan coating
• Blending (Bin and Static)
• Bilayer tablets
• Oven drying
- Packaging
• Clinical & commercial contract packaging
• Packaging facilities in the U.S. and EU
• Bottle filling
• Blister packaging
• Stick pack filling
- Powders
• Flow wrap packaging
• Repackaging licence
• Cartoning
• DEA Schedules II, 2N, III, 3N, IV, L1
• Serialisation & aggregation
Meet the Adare Pharma Solutions team at Stand #6F18 during CPHI Milan to find out more about our CDMO capabilities and how we can support your next project. Schedule a meeting at the show.
